Skip to main content

Clinical Care Advisory Board

The Clinical Care Advisory Board (CCAB) consists of a group of committed NF clinicians and patient representatives collaborating with CTF to identify ways to improve NF clinical care, educate patients and clinicians, and research relevant clinical care topics.

Menu

Main Functions of the CCAB

Identify and share best practices regarding NF care

Develop and maintain a network of quality NF care centers (NFCN)

Encourage the use of the NF Registry to advance NF knowledge and research

Approval of CTF educational materials

Advise CTF on matters related to the clinical care of NF patients

Current CCAB Projects

The CCAB and colleagues continue efforts to assess the delivery of guideline-driven care. The first part of the study surveyed clinicians on their awareness and agreement with current NF care guidelines. A patient survey is available every May through the NF Registry and asks patients and caregivers about their experiences with receiving NF care. This kind of input from the NF community is essential to understanding how CTF can improve clinical care for NF patients.

Additionally, the CCAB is assessing ways to improve health equity and developing an approach to establishing best care practices. CCAB members are committed to clinician education and networking by organizing monthly case conferences for NF Clinic Network members and organizing a half-day clinical session at the NF Conference.

The CCAB team and its committees continue to meet at least monthly to collaborate on how to continue to improve clinical care for the NF community. CTF also involves CCAB members in feedback and approval of CTF patient resources.

Co-Chairs
A man in a suit and tie smiling in front of a window.

Scott Plotkin, MD, PhD

Massachusetts General Hospital

Read Bio
A woman in a white lab coat smiling.

Laura Klesse, MD, PhD

UT Southwestern Medical Center

Read Bio
Clinician Members
A smiling man in a suit and tie.

Oliver F. Adunka, MD, FACS

The Ohio State University

Read Bio
A woman in a lab with her arms crossed.

Jaishri Blakeley, MD

Johns Hopkins University

Read Bio
A man in a blue shirt and tie.

Gary Brenner, MD, PhD

Massachusetts General Hospital

Read Bio
A man in a suit and tie smiles in front of bushes.

Jan Friedman, MD, PhD

University of British Columbia

Read Bio
A woman with long brown hair smiling for the camera.

Jennifer Janusz, PsyD, ABPP-Cn

Children’s Hospital Colorado

Read Bio
A male doctor wearing glasses and a tie.

Justin Jordan, MD, MPH

Massachusetts General Hospital

Read Bio
A woman in glasses is smiling in front of a window.

Bonnie Klein-Tasman, PhD

University of Wisconsin-Milwaukee

Read Bio
A woman in a black top smiling in front of bushes.

Tena Rosser, MD

Children’s Hospital of Los Angeles

Read Bio
A smiling woman in a white lab coat.

Pamela Trapane, MD, MME

UF Health Jacksonville

Read Bio
A portrait of a woman wearing a pink shirt.

Nicole Ullrich, MD, PhD

Boston Children’s Hospital

Read Bio
A man with a beard and a blue shirt.

David Viskochil, MD, PhD

University of Utah

Read Bio
Patient Representatives
A man wearing glasses and a blue shirt in front of a building.

Alwyn Dias, MSW, ACC

NF1 Patient Representative

Read Bio
A woman in a business suit posing for a photo.

Reema Bogin

NF2-SWN Patient Representative

Read Bio
A smiling man wearing glasses and a blue polo shirt.

Dale Berg

SWN Patient Representative

Read Bio
Contributors
A smiling woman in a black and white polka dot shirt.

Vanessa Merker, PhD

Massachusetts General Hospital

Read Bio
A smiling woman in a blue top.

Katie Metrock, MD

University of Alabama at Birmingham

Read Bio
A bald man in a suit and tie smiling.

Kaleb Yohay, MD

NYU Langone Medical Center

Read Bio
CTF Staff
An older woman smiling in a business suit.

Ledare Finley, MS, LCGC

Clinical Program Manager

Read Bio
A woman wearing glasses and a purple shirt.

Heather Radtke, MS, CGC

Director, Clinical Programs

Read Bio
Scott Plotkin, MD, PhD
Massachusetts General Hospital
Laura Klesse, MD, PhD
UT Southwestern Medical Center
Oliver F. Adunka, MD, FACS
The Ohio State University
Jaishri Blakeley, MD
Johns Hopkins University
Gary Brenner, MD, PhD
Massachusetts General Hospital
Jan Friedman, MD, PhD
University of British Columbia
Jennifer Janusz, PsyD, ABPP-Cn
Children’s Hospital Colorado
Justin Jordan, MD, MPH
Massachusetts General Hospital
Bonnie Klein-Tasman, PhD
University of Wisconsin-Milwaukee
Tena Rosser, MD
Children’s Hospital of Los Angeles
Pamela Trapane, MD, MME
UF Health Jacksonville
Nicole Ullrich, MD, PhD
Boston Children’s Hospital
David Viskochil, MD, PhD
University of Utah
Alwyn Dias, MSW, ACC
NF1 Patient Representative
Reema Bogin
NF2-SWN Patient Representative
Dale Berg
SWN Patient Representative
Vanessa Merker, PhD
Massachusetts General Hospital

Vanessa L. Merker, PhD, is a health services researcher at Massachusetts General Hospital and an Assistant Professor in Neurology at Harvard Medical School. Her research program leverages information collected directly from patients and their family members to improve clinical trial design and health care delivery for rare, genetic diseases like neurofibromatosis and schwannomatosis. By using research methods such as in-depth qualitative interviews and patient-reported outcome measures, she seeks to highlight patients’ priorities and tailor clinical interventions to match their preferences.

Dr. Merker is also committed to partnering with NF families to help design and disseminate research. As Chair of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REINS) International Collaboration Patient Representative working group, she helps enable NF patients/caregivers to give feedback on the design of new research studies.

As a CTF Clinical Care Advisory Board Contributor, Dr. Merker helps measure how well clinical care guidelines are being adopted across the U.S., with the aim of improving the quality of healthcare for people with all forms of NF.

Katie Metrock, MD
University of Alabama at Birmingham

Katie Metrock, MD completed a pediatric hematology-oncology fellowship and neuro-oncology fellowship at Emory University. She is currently a faculty member at the University of Alabama at Birmingham (UAB) and Children’s of Alabama. Dr. Metrock is the Director of the UAB Pediatric Neuro-Oncology Fellowship program. She is the Director of the Alabama Center for Childhood Cancer and Blood Disorders Pediatric Neurofibromatosis Tumor Clinic.

Her research interests through the NF Clinical Trials Consortium (NTCTC) include the use of Poly-ICLC for Pediatric NF1-associated Low-Grade Gliomas and Selumetinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Neurofibromatosis Type 1. She serves as the Co-Chair of the Quality Assurance Committee for the NFCTC and is a Course Co-Director of CTFs Virtual Case Conference.

She is also a CTF Clinical Care Advisory Board Contributor.

Kaleb Yohay, MD
NYU Langone Medical Center

Dr. Kaleb Yohay earned his medical degree at the University of Vermont in 1993.  He then completed pediatrics and neurology residency is at Johns Hopkins Hospital in Baltimore Maryland. While on faculty at Johns Hopkins, he cofounded the Johns Hopkins Neurofibromatosis Center.

Currently Dr. Yohay is an Associate Professor of Neurology and Pediatrics (Clinical) and Director of the NYU Langone Health Comprehensive Neurofibromatosis Center in New York City, one of the largest and most active neurofibromatosis clinics in the United States. His medical practice is devoted entirely to the care of children and adults with NF1, NF2 and schwannomatosis.  He is particularly interested in developing best practices for symptom screening, treatment, and age-appropriate anticipatory guidance for children and adults with neurofibromatosis and recently participated in the publication of the first clinical guidelines for the management of adults with neurofibromatosis 1.

Dr. Yohay’s research career has focused on the development and implementation of new therapeutics for neuro-oncologic and neuro-genetic disorders, including a gene therapy trial for the treatment of Late Infantile Neuronal Ceroid Lipofuscinosis, convection enhanced drug delivery for pontine glioma, and clinical trials for neurofibromatosis.

Dr. Yohay was full member of the CCAB from 2016-2022 and has been a key contributor on several CCAB projects since 2023.

Ledare Finley, MS, LCGC
Clinical Program Manager

Ledare Finley is the Clinical Program Manager at CTF and joined the Foundation in 2023. She is a licensed, board-certified genetic counselor with a BS in Cell Biology from the University of Tennessee and an MS degree in Genetic Counseling from the University of North Carolina at Greensboro. Ms. Finley has more than a decade of experience as a clinical and laboratory genetic counselor. As a clinical genetic counselor, she has served pediatric and adult patients in general genetics as well as patients in hereditary cancer genetics. She also has experience as a laboratory genetic counselor in clinical genomics and molecular genetics.

Ms. Finley’s goals are to expand and enhance the NF Clinic Network (NFCN). She serves as one of the CTF liaisons to the Clinical Care Advisory Board, supporting efforts to improve the care of NF patients.

Ms. Finley has been one of the CTF liaisons of the CCAB since 2023.

Ledare Finley, MS, LCGC
Director, Clinical Programs

 Email: hradtke@ctf.org

Ms. Radtke is the Neurofibromatosis Clinic Network Manager at CTF and joined the foundation in 2014. She is a board-certified genetic counselor with a BS degree in Genetics from the University of Wisconsin – Madison and a MS degree in Genetic Counseling from the University of Colorado Health Sciences Center. She oversees the NF Clinic Network (NFCN) with ongoing efforts to encourage collaboration and mentorship of NF clinicians and a goal to improve access to quality NF care.

Ms. Radtke has over 20 years of clinical and coordinator experience with NF and other RASopathy disorders. In addition to her role at CTF, she works at the Medical College of Wisconsin in the NF/RASopathy Center. Ms. Radtke has published a practice resource for genetic counseling in NF and created some of CTF patient resources, including a booklet for teens and young adults with NF1 and microdeletion NF1. She is involved in transition readiness research with a goal to use this data to develop effective transition programs for patients and clinicians in NF clinics.

Ms. Radtke has been one of the CTF liaisons of the CCAB since 2014.